Please login to the form below

Not currently logged in
Email:
Password:

Firmagon

This page shows the latest Firmagon news and features for those working in and with pharma, biotech and healthcare.

NICE finally set to back wider use of Ferring's Firmagon

NICE finally set to back wider use of Ferring's Firmagon

NICE finally set to back wider use of Ferring's Firmagon. And acknowledges drug's benefits for prostate cancer that spreads to the spine. ... Ferring's Firmagon (degarelix) has been recommended for use by the NHS in England by the country's

Latest news

  • NICE gives partial backing to Ferring's prostate cancer drug NICE gives partial backing to Ferring's prostate cancer drug

    NICE gives partial backing to Ferring's prostate cancer drug. Firmagon on course for use on NHS in England and Wales. ... said. "Patients with pre-existing CVD are most at risk and the evidence shows that Firmagon has a higher chance of reducing that.".

  • Close but no cigar

    Acanya (Arcutis, Dow). Acne vulgaris. US, Europe. Degarelix. FIRMAGON (Ferring). Prostate cancer.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics